Stockreport

InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance [Yahoo! Finance]

InMed Pharmaceuticals Inc. - Common Shares  (INM) 
PDF the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced that it has received a notification letter [Read more]